Pharmsville
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Pharmsville develops and manufactures health functional foods and wellness-oriented food products, think dietary supplements, vitamins, and diet-support foods, for everyday consumers in South Korea.
It distributes these products through its own online shopping platforms and through partnerships with major online retailers, reaching consumers directly. Listed on KOSDAQ, South Korea's tech and small-cap board, the company operates more than a dozen proprietary brands, each targeting distinct consumer segments such as general wellness, weight management, and vitamins.
Summary is AI-generated and may contain errors · figures from DART filings
One of its flagship platforms, 'Appletree Kim Pharmacist,' is a health-food specialist channel where licensed pharmacists provide one-on-one consumer consultations, an unusual retail model in this category.
Pharmsville in five facts
What does Pharmsville do?
Pharmsville develops and manufactures health functional foods and wellness-oriented food products, think dietary supplements, vitamins, and diet-support foods, for everyday consumers in South Korea.
Where is Pharmsville listed and in which sector?
Pharmsville (Korean name: 팜스빌) trades under KRX code 318010 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Staples sector, Food & Beverage.
How large is Pharmsville?
Its market capitalisation was US$20.7M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Pharmsville's latest annual revenue and operating profit?
For fiscal year 2025, Pharmsville reported revenue of US$9.6M, an operating loss of US$508.1K and net income of US$2.2M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was down 23.9% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Cash/in-kind dividend decision
Pharmsville declared a cash dividend of US$0.14 per share, equal to about 5.7% of the recent share price.
Dividend · Mar 11 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Pharmsville reported consolidated results for FY2025: revenue of US$8.73M (−23.9% year on year), an operating loss of US$462K and net income of US$2.15M (+97.8% year on year).
Earnings · Feb 10